FDA Clears Of Its Spectra VRM III Q-Switched Nd:Yag Laser System For Treating A Broad Spectrum Of Dermatological And Aesthetic Conditions

Lutronic has announced that it has received FDA
clearance to market its Spectra VRM III. This dual pulse
Q-Switched Nd:Yag laser is the feature-rich successor to the
Spectra VRM II. The laser produces 4 wavelengths (1064 nm,
532 nm, 585 nm, 650 nm) in Q-switched nanosecond pulse. It
is specifically designed to treat a wide array of
dermatological and aesthetic conditions, including dermal
and epidermal pigmented lesions, muticolor tattoos, melasma,
and active acne. It further enables laser toning, and
non-ablative photo-acoustic skin rejuvenation techniques.



The laser incorporates a dual pulse mode, which enables it
to produce very short and quasi-long microsecond pulses.
There are numerous advantages which result from the unique
pulse characteristics not found in other lasers including
extreme high peak power and a flat-top beam profile. "The
VRM III is extremely effective for the treatment of melasma.
I have been achieving near 100% clearance on melasma
treatment therapy. This is very impressive because melasma
is traditionally thought to be treatment resistant. Further,
the VRM has also been highly effective for the treatment of
Post-Inflammatory Hyperpigmentation that may result as
adverse side affects from other lasers or IPL treatments,"
explains Dr. Sooil Chun, the clinical professor of Yonsei
University. The company states that further scientific works
are being conducted for this treatment in an effort to
collect additional empirical data for peer reviewed studies.



As tattoo removal is becoming one of the fastest-growing
treatment groups, the 4 wavelength option offered by the VRM
III laser enables treatment of a wide range of colors. The
laser's flat-top beam profile provides increased patient
comfort and reduced pinpoint bleeding, resulting in fewer
side effects and significantly faster healing. The fine
control of the 532 nm wavelength feature assures that
epidermal lesions are treated with measurably less potential
for PIH.



With an installed base of over 2000 VRM series units
globally, the new VRM III is proving to be the workhorse
system of choice for laser clinics around the world.



About Lutronic



Lutronic is one of the world's leading developers and
manufacturers of medical laser systems serving the clinical
dermatological and aesthetic communities. With over a decade
of award-winning technology design that includes its Spectra
line of products and its unparalleled MOSAIC Systems, the
company is committed to delivering innovative, highly
effective, and painless laser solutions. Strategically
headquartered in Princeton Junction, NJ (on the Route 1
corridor between New York City and Philadelphia), Lutronic
Inc. maintains an extensive national network of
distributors, including MedEdge, Elite Medical, and
Aesthetic Technologies of Florida. In addition, Lutronic
Inc. offers an impressive service department featuring
experienced laser engineers who provide the highest level of
service and support to physicians across the US.
Manufacturing medical laser systems for markets in Europe
and Asia, parent Lutronic Co. Ltd. is based in Seoul, South
Korea and delivers product to over 40 countries.


lutronic